Cost and mortality impact of an algorithm-driven sepsis prediction system
- 3 April 2017
- journal article
- critical care
- Published by Taylor & Francis in Journal of Medical Economics
- Vol. 20 (6) , 646-651
Abstract
Aims: To compute the financial and mortality impact of InSight, an algorithm-driven biomarker, which forecasts the onset of sepsis with minimal use of electronic health record data. Methods: This study compares InSight with existing sepsis screening tools and computes the differential life and cost savings associated with its use in the inpatient setting. To do so, mortality reduction is obtained from an increase in the number of sepsis cases correctly identified by InSight. Early sepsis detection by InSight is also associated with a reduction in length-of-stay, from which cost savings are directly computed. Results: InSight identifies more true positive cases of severe sepsis, with fewer false alarms, than comparable methods. For an individual ICU with 50 beds, for example, it is determined that InSight annually saves 75 additional lives and reduces sepsis-related costs by $560,000. Limitations: InSight performance results are derived from analysis of a single-center cohort. Mortality reduction results rely on a simplified use case, which fixes prediction times at 0, 1, and 2 h before sepsis onset, likely leading to under-estimates of lives saved. The corresponding cost reduction numbers are based on national averages for daily patient length-of-stay cost. Conclusions: InSight has the potential to reduce sepsis-related deaths and to lead to substantial cost savings for healthcare facilities.Keywords
This publication has 28 references indexed in Scilit:
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Assessment of Clinical Criteria for SepsisJAMA, 2016
- Two Decades of Mortality Trends Among Patients With Severe SepsisCritical Care Medicine, 2014
- The Economics of SepsisCritical Care Clinics, 2012
- Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality*Critical Care Medicine, 2007
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Pharmacoeconomic implications of new therapies in sepsis.PharmacoEconomics, 2004
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 2001
- The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)JAMA, 1995